Cannabis Stock Gainers And Losers From June 4, 2024
GAINERS:Affinor Growers (OTC:RSSFF) shares closed up 91.58% at $0.12Cann Gr (OTC:CNGGF) shares closed up 76.67% at $0.05SOL Glb Inv (OTC:SOLCF) shares closed up 43.12% at $0.04Maple Leaf Green World (
Canopy Growth Corp Price Target Raised to C$11.00/Share From C$6.00 by Alliance Global Partners
Canopy Growth Corp Price Target Raised to C$11.00/Share From C$6.00 by Alliance Global Partners
Canopy Growth Exercises Option to Acquire Acreage Class E Shares Following on 2019 Acquisition Agreement
Canopy Growth (WEED.TO, CGC) edged down in premarket Nasdaq trading after the cannabis company on Tuesday said it exercised an option to acquire all of the Class E subordinate voting shares of Acreage
A. G. P. Maintains Canopy Growth(CGC.US) With Hold Rating, Raises Target Price to $8.07
A. G. P. analyst Aaron Grey maintains $Canopy Growth(CGC.US)$ with a hold rating, and adjusts the target price from $4.36 to $8.07.According to TipRanks data, the analyst has a success rate of 28.6% a
Canopy Growth: Acreage Will Become Wholly-Owned Subsidiary of Canopy USA >CGC
Canopy Growth: Acreage Will Become Wholly-Owned Subsidiary of Canopy USA >CGC
Canopy Growth Exercises Option to Acquire All Issued and Outstanding Class E Subordinate Voting Shares of Acreage Holdings >CGC
Canopy Growth Exercises Option to Acquire All Issued and Outstanding Class E Subordinate Voting Shares of Acreage Holdings >CGC
Canopy Growth Announces Exercise of Acreage Options Paving the Way for Acquisition by Canopy USA
Press ReleasesCanopy Growth Announces Exercise of Acreage Options Paving the Way for Acquisition by Canopy USAJun. 4, 2024Canopy USA completes acquisition of Jetty and advances acquisition of WanaSMIT
Executive Changes In Marijuana Industry You Should Know About, New Cannabis Appointments & More
As the 19th Benzinga Cannabis Capital Conference returns to Chicago (Oct. 8-9), gathering top CEOs, investors and leaders in the marijuana industry, let's scroll through the latest leadership changes
Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going
In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024. The report highlights a deceleration in market growth and notable shi
Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 3, 2024
GAINERS:1933 Industries (OTC:TGIFF) shares closed up 31.87% at $0.01CV Sciences (OTC:CVSI) shares closed up 17.65% at $0.08Eastside Distilling (NASDAQ:EAST) shares closed up 9.80% at $1.04Corbus Pharm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Week of 6/2/24
Piper Sandler Maintains Underweight On Canopy Growth Stock, Calls Cannabis Rescheduling 'Largely Symbolic'
A recent company note from Piper Sandler & Co, by senior analysts Michael S. Lavery and Luke Maloney offers insights into Canopy Growth Corporation's (NASDAQ:CGC) financial performance, valuation and
Piper Sandler Reviews Canopy Growth's Q4
Canopy Growth Corporation reported a fourth quarter revenue beat but EBITDA was well below Piper Sandler estimates. Management reaffirmed its expectations to achieve positive adjusted EBITDA in H2 202
Canopy Growth Corp. Is Maintained at Underperform by CIBC World Markets
Canopy Growth Corp. Is Maintained at Underperform by CIBC World Markets
Acreage's Q1 Revenue Slips 19% YoY But CEO Foresees 'Significant Growth Opportunities' As Canopy Growth Strategy Moves Forward
Multi-state cannabis operator Acreage Holdings, Inc. (CSE:ACRG, ACRG.B.U))) (OTCQX:ACRHF, ACRDF))), reported its financial results on Friday for the first quarter ended March 31, 2024."In the first qu
Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Canopy Growth (CGC) and BioMarin Pharmaceutical (BMRN)
Canopy Growth's Strategic Positioning and Market Potential Propel Positive Analyst Outlook
Canopy Growth's Battle Against Unregulated Cannabis Rivals: A Threat to Market Fairness and Financial Stability
Earnings Call Summary | Canopy Growth(CGC.US) Q4 2024 Earnings Conference
The following is a summary of the Canopy Growth Corporation (CGC) Q4 2024 Earnings Call Transcript:Financial Performance:Reported Q4 FY24 organic revenue growth of 16% compared to Q4 FY23.Consolidated
Analysts Conflicted on These Healthcare Names: Canopy Growth (CGC), Ultragenyx Pharmaceutical (RARE) and Roivant Sciences (ROIV)
No Data